^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    4SCAR-T

    i
    Other names: 4SCAR-T, 4SCAR-CD22/CD123/CD38/CD10/CD20 infusion
    Associations

    News

    Trials
    Company:
    SZGIMI
    Drug class:
    CD20-targeted CAR-T immunotherapy, CD123-targeted CAR-T immunotherapy, CD22-targeted CAR-T immunotherapy, CD10-targeted CAR-T immunotherapy, CD38-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    4years
    4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma (clinicaltrials.gov)
    P1/2, N=100, Recruiting, Shenzhen Geno-Immune Medical Institute
    Clinical • New P1/2 trial
    |
    CD276 (CD276 Molecule)
    |
    4SCAR-T
    over4years
    Multi-4SCAR-T Therapy Targeting Breast Cancer (clinicaltrials.gov)
    P1/2, N=100, Recruiting, Shenzhen Geno-Immune Medical Institute
    New P1/2 trial • CAR T-Cell Therapy
    |
    HER-2 (Human epidermal growth factor receptor 2) • CD44 (CD44 Molecule)
    |
    HER-2 expression • CD44 expression
    |
    4SCAR-T
    over4years
    4SCAR-T Therapy Post CD19-targeted Immunotherapy (clinicaltrials.gov)
    P1/2, N=100, Recruiting, Shenzhen Geno-Immune Medical Institute
    New P1/2 trial
    |
    CD20 (Membrane Spanning 4-Domains A1) • CD38 (CD38 Molecule) • CD123 (Interleukin 3 Receptor Subunit Alpha) • CD22 (CD22 Molecule) • MME (Membrane Metalloendopeptidase)
    |
    4SCAR-T